Global Veterinary Biologics Market: Overview

Immunity is a biological defense mechanism to avoid infection or disease. When the autoimmune system fails, biologic drugs play a vital role in defending against diseases or infections by boosting the immune system. Veterinary biologics are products derived from living organisms and biological processes. These are used to prevent, diagnose, or treat animal diseases and function through an immunological process.

Global Veterinary Biologics Market: Key Trends

Rise in prevalence of animal diseases, increase in disposable income, focus of major players in the research and development of new vet biologic products to combat new animal diseases are projected to drive demand for veterinary biologics products. Moreover, increase in investments by government bodies and rise in demand for milk, meat, eggs, and fish are the other factors anticipated to propel the global veterinary biologics market during the forecast period.

Global Veterinary Biologics Market: Segmentation

The global veterinary biologics market can be segmented based on product, disease type, animal type, distribution channel, and region. In terms of product, the global market can be classified into vaccines, diagnostic kits, immunomodulators, antiserums & antibodies, and others. The vaccines segment can be categorized into inactivated vaccines, conjugate vaccines, live attenuated, and toxoid vaccines. The vaccines segment is projected to account for significant share of the market in the near future. This is because of technological advances in vaccine development, continuous development of drug resistance by pathogens, and emergence of new diseases. Moreover, veterinary vaccine development generally has less stringent regulatory and preclinical trial requirements. Therefore, new players have the opportunity to enter the market through new product development. Based on animal type, the global veterinary biologics market can be bifurcated into livestock animals and companion animals. Usage of veterinary biologics is higher in livestock animals. Hence, the livestock animals segment is anticipated to dominate the market. Livestock animals are more prone to new diseases. Hence, proper vaccination is required. In terms of disease type, the market can be divided into bluetongue, foot & mouth disease, brucellosis & tuberculosis, and others. Based on distribution channel, the global veterinary biologics market can be classified into veterinary hospitals, veterinary clinics, and others. The veterinary hospitals segment dominated the market in 2017 due to favorable government support and availability of all types of vet treatment.

Global Veterinary Biologics Market: Regional Analysis

In terms of region, the global veterinary biologics market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017. The region is projected to account for significant share of the global veterinary biologics market during the forecast period, owing to increase in concerns about pet health and high cost of products. Favorable government support for the development of new biologic drugs is anticipated to drive the market in Europe. In December 2015, the Biotechnology and Biological Sciences Research Council (BBSRC) funded GBP 5.7 Mn for the development of poultry vaccines to the London School of Hygiene and Tropical Medicine. A rising trend of zoonotics, mandatory government requirement for immunization of animals, and trend of keeping companion animals are the major factors that drive the veterinary biologics market in Asia Pacific.

Global Veterinary Biologics Market: Competitive Landscape

Major players operating in the global veterinary biologics market include Zoetis, Inc., Merck Animal Health, Boehringer Ingelheim GmbH, Bayer AG, Eli Lilly & Company, Abaxis, OMEGA, and Hebei Veyong Animal Pharmaceutical Co., Ltd.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Veterinary Biologics Market

Pre Book